Drug
Phenelzine
Phenelzine is a pharmaceutical drug with 3 clinical trials. Historical success rate of 100.0%.
Total Trials
3
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 2 completed trials
Completion Rate
100%(2/2)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_1
2
67%
Ph phase_4
1
33%
Phase Distribution
2
Early Stage
0
Mid Stage
1
Late Stage
Phase Distribution3 total trials
Phase 1Safety & dosage
2(66.7%)
Phase 4Post-market surveillance
1(33.3%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
100.0%
2 of 2 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
3
all time
Status Distribution
Active(1)
Completed(2)
Detailed Status
Completed2
Enrolling by invitation1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Phase 12 (66.7%)
Phase 41 (33.3%)
Trials by Status
enrolling_by_invitation133%
completed267%
Recent Activity
0 active trials
Showing 3 of 3
enrolling_by_invitationphase_4
Precision Care for Major Depressive Disorder
NCT06580041
completedphase_1
Study to Evaluate the Pressor Effect of Oral Tyramine During Ozanimod Treatment in Healthy Adult Participants
NCT04978298
completedphase_1
Drug-drug Interaction Study of Ozanimod With Tyramine to Evaluate the Effect on Pressor Response
NCT03694119
Clinical Trials (3)
Showing 3 of 3 trials
NCT06580041Phase 4
Precision Care for Major Depressive Disorder
NCT04978298Phase 1
Study to Evaluate the Pressor Effect of Oral Tyramine During Ozanimod Treatment in Healthy Adult Participants
NCT03694119Phase 1
Drug-drug Interaction Study of Ozanimod With Tyramine to Evaluate the Effect on Pressor Response
All 3 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 3